Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach-Reference-Cited by-同舟云学术

Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach

Published:2024-04 Issue: Volume:34 Page:125-137
ISSN:2452-199X
Container-title:Bioactive Materials
language:en
Short-container-title:Bioactive Materials

Author:

Young Rachel E.^ORCID,Nelson Katherine M.^ORCID,Hofbauer Samuel I.,Vijayakumar Tara,Alameh Mohamad-Gabriel,Weissman Drew^ORCID,Papachristou Charalampos^ORCID,Gleghorn Jason P.^ORCID,Riley Rachel S.^ORCID

Funder

National Science Foundation

National Institutes of Health

New Jersey Health Foundation

State of New Jersey Department of Health

Publisher

Elsevier BV

Subject

Biomedical Engineering,Biomaterials,Biotechnology

Reference79 articles.

1. An mRNA vaccine against SARS-CoV-2 - preliminary report;Jackson;N. Engl. J. Med.,2020

2. Safety and efficacy of RNAi therapy for transthyretin amyloidosis;Coelho;N. Engl. J. Med.,2013

3. Treatment of hemophilia A using factor VIII messenger RNA lipid nanoparticles;Chen;Mol. Ther. Nucleic Acids,2020

4. Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA;Islam;Nat. Biomed. Eng.,2018

5. Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition;Kong;Sci. Transl. Med.,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of helper lipids in optimising nanoparticle formulations of self-amplifying RNA;Journal of Controlled Release;2024-10

2. Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy;Journal of Controlled Release;2024-08

3. Placental Drug Delivery to Treat Pre‐Eclampsia and Fetal Growth Restriction;Small;2024-05-15

4. Lipid nanoparticles for local delivery of mRNA to the respiratory tract: Effect of PEG-lipid content and administration route;European Journal of Pharmaceutics and Biopharmaceutics;2024-05

5. Progress in novel delivery technologies to improve efficacy of therapeutic antibodies;Antiviral Research;2024-05